Immunoscore in the WHO Classification of Digestive System Tumours
04 mars 2020 12h30 HE
|
HalioDx
Immunoscore® in the WHO Classification of Digestive System Tumours Immune response is now part of the Essential and Desirable Diagnostic Criteria for Colorectal Cancers in the 5th edition of the...
Immunoscore to support Immuno-oncology and microbiome research within the ONCOBIOME consortium
30 sept. 2019 08h00 HE
|
HalioDx
Immunoscore® to support Immuno-oncology and microbiome research within the ONCOBIOME consortium A 15M€ European granted consortium led by Laurence Zitvogel from Gustave Roussy in Villejuif.HalioDx...
HalioDx lève 18,5 millions d'euros dans un tour de Série B
17 janv. 2018 01h00 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Communiqué de presse 17...
HalioDx closed a Series B round of €18.5 million (US$22.3 million)
17 janv. 2018 01h00 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release ...
HalioDx receives CLIA Compliance for Immunoscore® Colon
21 juin 2017 11h00 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
HalioDx receives CLIA Compliance for...
HalioDx : Immunosign® gene signature assesses LTX-315 ability to turn 'cold' tumors 'hot' at ASCO 2017
05 juin 2017 09h00 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Immunosign® gene signature assesses...
HalioDx : HalioDx highlights use of Immunosign® to define CAR T-cell therapy signature in tumor at ASCO 2017
05 juin 2017 09h00 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
HalioDx highlights use of Immunosign® to...
HalioDx : Immunoscore Colon prognostic performance confirmed in data presented by Mayo Clinic at ASCO 2017
03 juin 2017 09h00 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Immunoscore® Colon prognostic performance...
HalioDx : Immunoscore®, Immunosign® and Halioseek(TM) at ASCO 2017
23 mai 2017 11h30 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Immunoscore®, Immunosign® and...
HalioDx: New data on Halioseek(TM) PD-L1/CD8 presented at AACR 2017
31 mars 2017 13h09 HE
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
New data on Halioseek(TM) PD-L1/CD8...